Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

NCT04338867 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Phase II Clinical Trial
Ninety-six Histologically Confirmed NSCLC Patients With BM
Randomized 1:1 to Received TN Plus WBR or Only WBR
ICPFS Evaluated by Two Blinded and Independent Radio-oncologist With MRI

Interventions

RADIATION: Whole-brain radiotherapy

Sponsor

Instituto Nacional de Cancerologia de Mexico